CGEN #

Related by string. * : Compugen NASDAQ CGEN . Compugen CGEN . NASDAQ CGEN announced . NASDAQ CGEN . Nasdaq CGEN . CGEN Digital . TASE CGEN . CGEN / # [012] . # [007] . # [016] . #s [002] . # [014] . #s [004] . # [004] . # [022] . -# [001] . # [009] : #.# ov #-# . #-#:# pm [001] . ID # # . i Newswire #-#-# . Call #-#-# [002] . #-#-# ATS [003] . #-#-# ATS [002] . +#-#-#-# [004] . #-#-# #ET Copyright c * *

Related by context. Frequent words. (Click for all words.) 68 Preclinical studies 67 #ME# 67 OXi# 66 vivo efficacy 66 Homspera 65 Azedra 65 oral bioavailability 65 immunomodulatory 65 TRIOLEX 65 vitro experiments 64 LY# [003] 64 vitro studies 64 CA4P 64 exon skipping 63 HuMax CD# 63 antitumor 63 Revimmune 63 immunomodulator 63 Protectan CBLB# 63 anticancer agent 63 DP b# 62 Serdaxin 62 xenograft models 62 CBLB# 62 MultiStem 62 KNS # 62 Valortim 62 HCV protease inhibitor 62 Cethrin 62 Aurora kinase 62 cardiac toxicity 62 tezampanel 62 orally bioavailable 62 Voreloxin 62 preclinical models 62 Synavive 62 PXD# 62 ISIS # 61 partial agonist 61 preclinical studies 61 Elesclomol 61 NEUMUNE 61 diabetic neuropathic pain 61 anti proliferative 61 INGN 61 talabostat 60 BAY #-# 60 tesmilifene 60 zileuton 60 angiogenesis inhibitor 60 Hsp# inhibitors 60 Kevetrin 60 Laquinimod 60 immune modulation 60 PLX# 60 tanespimycin 60 CYT# 60 potent inhibitor 60 muraglitazar 60 axitinib 60 Crofelemer 60 MAXY G# 60 anti angiogenic 60 Opexa 59 methylnaltrexone 59 induce apoptosis 59 antitumor activity 59 PS# [001] 59 Ampligen R 59 eltrombopag 59 therapeutic monoclonal antibodies 59 laquinimod 59 liver fibrosis 59 decitabine 59 BiTE antibody 59 RGB # 59 upregulation 59 calcitonin 59 antithrombotic 59 Phase 2a trial 59 MGCD# [001] 59 ANAVEX #-# [003] 59 anticancer therapy 59 siRNA delivery 59 Hedgehog pathway 59 GPR# [002] 59 itraconazole 59 Hsp# inhibitor 59 INCB# [002] 59 anti VEGF 58 NeuroVax TM 58 Debio 58 TREANDA 58 aclidinium 58 HDAC inhibitors 58 pterostilbene 58 Erlotinib 58 Desmoteplase 58 humanized anti 58 malignant transformation 58 Alemtuzumab

Back to home page